Skip to content
Clinical Trials – home

Uppsala University Hospital

Verifiedinfo

Sweden P. O. Box 591, 751 24 Uppsala, Sweden

  • 8 trials recruiting
  • Prostate cancer · Systemic mastocytosis · Cardiac failure
  • Adult patients

About Specializations

Uppsala University Hospital in Uppsala, Sweden specialises in clinical trials of conditions such as Prostate cancer, Systemic mastocytosis, Cardiac failure, Oesophageal squamous cell carcinoma, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases Research

At Uppsala University Hospital, the clinical trial portfolio focuses on cardiovascular diseases, with studies centered on serious conditions affecting the heart and brain circulation. The research is exploring whether new treatment approaches can improve outcomes for patients and support better clinical decision-making in everyday care.

  • Stroke care and the evaluation of treatments aimed at reducing early death after intracerebral haemorrhage
  • Takotsubo syndrome and efforts to improve symptom control and overall recovery
  • Testing whether established medicines may offer better protection against complications in high-risk patients

This work includes assessing the clinical value of tranexamic acid in acute brain bleeding and studying treatment strategies for Takotsubo syndrome, a heart condition often linked to severe stress.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
P. O. Box 591751 24 UppsalaSweden
Recruiting now
8 trials
Conditions studied
16
Partner status
Verified

More sites in UppsalaSweden

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

12 clinical trials

Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:AstraZeneca AB
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Avapritinib
  • Sponsor:Blueprint Medicines Corp.

Cardiac failure

Recruiting
Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:AstraZeneca AB
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Karolinska University Hospital
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Adenosine
  • Sponsor:Vaestra Goetalandsregionen
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Aprepitant
  • Sponsor:Karolinska University Hospital
Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:University Of Nottingham
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Bupropion Hydrochloride
  • Sponsor:Uppsala University
Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Celgene Corp.
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Incyte Corp.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.